InProTher receives 2.5M EUR in funding through the European Innovation Council Accelerator

15 Oct 2021
By InProTher

We are beyond proud to announce that InProTher is one of just 65 European companies to receive funding through the European Innovation Council Accelerator. Being selected among more than 4000 applicants, the funding of €2.5m

Related news

NEWS

Inprother will be presenting at Biotech Showcase 2020

03 Dec 2019

By InProTher

NEWS

InProTher announces EUR 6MSeed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy

24 May 2023

By InProTher

NEWS

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)

05 Feb 2020

By InProTher

NEWS

Postdoctoral grant allows InProTher to engage in new exciting collaborations

30 Oct 2020

By InProTher